Collaboration with aTyr Pharma Announces Research

Dualsystems Biotech is very excited to start a 3 year non-exclusive collaboration with aTyr Pharma to identify 10 novel therapeutic drug targets.
With our LRC-TriCEPS platform we can identify targets on living cells and have identified in the past many novel interactions.

Dualsystems announces collaboration to identify new targets of Covid-19

Dualsystems Biotech AG celebrates its 20th Anniversary

Comparison of different Ligang-receptor identification methodologies by Dualsystems

New Publication – Validation of extracellular ligand–receptor interactions by Flow-TriCEPS

Dualsystems Biotech wins the 3rd price at the Sino-Europe Innovation Week in Healthcare Technology

HATRIC-based identification of receptors for orphan ligands (small molecules)

Scratching the surface: Technologies for targeting the cell surfaceome

Important new receptors for Follicum’s lead candidate FOL-005